Results 221 to 230 of about 61,341 (287)

Analyzing real-world adverse events of spironolactone with the FAERS database. [PDF]

PLoS One
Lin G, Chen R, Wen C, Li Z, Yan X, Li L.
europepmc   +1 more source

Plasma atrial natriuretic factor in patients with cirrhosis [PDF]

, 1985
Arendt, Rainer M., Gerbes, Alexander L., Jüngst, Dieter, Paumgartner, Gustav, Ritter, D., Zähringer, J.   +5 more
core  

Analytical Method Validation of Simultaneous Determination of Spironolactone and Furosemide in Tablet Formulation and its Statistical Evaluation [PDF]

, 2014
Rajesh R. Ram, Vijay Ram, H. S. Joshi
openalex   +1 more source

Efficacy and Safety of Oral Spironolactone for Women With Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials With Trial Sequential Analysis. [PDF]

J Cosmet Dermatol
Ghanem L, Kirmani N, De León Fernández N, Palacios-Ortiz MP, Rodríguez-Parra JD, Rusu CA.   +5 more
europepmc   +1 more source

Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial

JAMA cardiology, 2017
J. Butler, K. Anstrom, G. Felker, M. Givertz, A. Kalogeropoulos, M. Konstam, Douglas L. Mann, Kenneth B. Margulies, Steven E. McNulty, Robert J. Mentz, M. Redfield, W. W. Tang, D. Whellan, M. Shah, P. Desvigne‐Nickens, Adrian F. Hernandez, E. Braunwald   +16 more
semanticscholar   +1 more source

Effect of spironolactone on mineralo and glucocorticoid — induced increases in colonic NA and water absorption and Na-K-ATPase activity

, 1978
Alan N. Charney, Mark Donowitz, Cynthia Costenbader   +2 more
openalex   +1 more source

Spironolactone Targets Retinoid X Receptor γ to Promote Myelin Sheath Regeneration. [PDF]

Neurol Neuroimmunol Neuroinflamm
Sun QQ, Ai RS, Chai NN, Han B, Bao MY, Li YB, Ma GX, Wang LJ, Qian ZQ, Li X, Zhang Y.   +10 more
europepmc   +1 more source

Efficacy and safety of spironolactone for the treatment of patients with acute heart failure

, 2020
Yanlin Feng, Min Lü
openalex   +1 more source

Effect of spironolactone on cardiovascular and renal outcomes in patients with chronic kidney disease. [PDF]

Clin Kidney J
Chen TH, Ou SM, Lin KH, Ho Y, Tseng WC, Chu YC, Tarng DC.   +6 more
europepmc   +1 more source

Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation.

New England Journal of Medicine, 2017
S. de Denus, E. O’Meara, Akshay S. Desai, Brian Claggett, E. Lewis, Grégoire Leclair, Martin Jutras, J. Lavoie, S. Solomon, B. Pitt, M. Pfeffer, J. Rouleau   +11 more
semanticscholar   +1 more source